Prior high-risk HPV testing and Pap test results for 427 invasive cervical cancers in China's largest CAP-certified laboratory

Cancer Cytopathology

Volumn 123, Issue 7, 2015, Pages 428-434

  Zheng, Baowen ^a   Li, Zaibo ^b   Griffith, Christopher C ^c   Yan, Shanshan ^a   Chen, Congde ^a   Ding, Xiangdong ^a   Liang, Xiaoman ^a   Yang, Huaitao ^d   Zhao, Chengquan ^c  

^a Kingmed Diagnostic Company   (China)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

cervical cancer; China; histology; human papillomavirus (HPV); human papillomavirus test; Papanicolaou (Pap) test

Indexed keywords

ADULT; AGED; ARTICLE; CHINA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; ADENOCARCINOMA; AGE DISTRIBUTION; CLASSIFICATION; COMPARATIVE STUDY; EARLY DIAGNOSIS; FACTUAL DATABASE; INCIDENCE; ISOLATION AND PURIFICATION; LABORATORY; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PATHOLOGY; PROCEDURES; RETROSPECTIVE STUDY; RISK ASSESSMENT; TUMOR INVASION; UTERINE CERVICAL NEOPLASMS; VAGINA SMEAR; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

ADENOCARCINOMA; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHINA; DATABASES, FACTUAL; EARLY DETECTION OF CANCER; FEMALE; HUMANS; INCIDENCE; LABORATORIES; MIDDLE AGED; NEOPLASM INVASIVENESS; PAPANICOLAOU TEST; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 84942590303     PISSN: 1934662X     EISSN: 19346638     Source Type: Journal    
DOI: 10.1002/cncy.21557     Document Type: Article

References (28)

1. Walboomers JM, Jacobs MV, Manos MM, et al., Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999; 189: 12-19.
2. Katki HA, Kinney WK, Fetterman B, et al., Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice. Lancet Oncol. 2011; 12: 663-672.
3. Stoler MH, Wright TC Jr, Sharma A, Apple R, Gutekunst K, Wright TL,; ATHENA (Addressing the Need for Advanced HPV Diagnostics) HPV Study Group. High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study. Am J Clin Pathol. 2011; 135: 468-475.
4. Castle PE, Stoler MH, Wright TC Jr, Sharma A, Wright TL, Behrens CM,. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study. Lancet Oncol. 2011; 12: 880-890.
5. Wright TC Jr, Stoler MH, Behrens CM, Apple R, Derion T, Wright TL,. The ATHENA human papillomavirus study: design, methods, and baseline results. Am J Obstet Gynecol. 2012; 206: 46.e1-e46.
6. Naucler P, Ryd W, Tornberg S, et al., Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med. 2007; 357: 1589-1597.
7. Bulkmans NW, Berkhof J, Rozendaal L, et al., Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet. 2007; 370: 1764-1772.
8. Ronco G, Giorgi-Rossi P, Carozzi F, et al,; New Technologies for Cervical Cancer Screening (NTCC) Working Group. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol. 2010; 11: 249-257.
9. Massad LS, Einstein MH, Huh WK, et al,; ASCCP Consensus Guidelines Conference. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis. 2013; 17 (5 suppl 1): S1-S27.
10. Saslow D, Solomon D, Lawson HW, et al., American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol. 2012; 137: 516-542.
11. Li Z, Austin RM, Guo M, Zhao C,. Screening test results associated with cancer diagnoses in 287 women with cervical squamous cell carcinoma. Arch Pathol Lab Med. 2012; 136: 1533-1540.
12. Naryshkin S, Austin RM,. Limitations of widely used high-risk human papillomavirus laboratory-developed testing in cervical cancer screening. Drug Healthc Patient Saf. 2012; 4: 167-172.
13. Kang WD, Kim CH, Co MK, et al., Comparison of Hybrid Capture II assay with the human papillomavirus DNA chip test for the detection of high-grade cervical lesions. Int J Gynecol Cancer. 2009; 19: 924-928.
14. Zhao C, Li Z, Austin RM,. Cervical screening test results associated with 265 histopathologic diagnoses of cervical glandular neoplasia. Am J Clin Pathol. 2013; 140: 47-54.
15. Kinney W, Fetterman B, Cox JT, Lorey T, Flanagan T, Castle PE,. Characteristics of 44 cervical cancers diagnosed following Pap-negative, high risk HPV-positive screening in routine clinical practice. Gynecol Oncol. 2011; 121: 309-313.
16. Bohmer G, van den Brule AJC, Brummer O, Meijer CJLM, Petry KU,. No confirmed case of human papillomavirus DNA-negative cervical intraepithelial neoplasia grade 3 or invasive primary cancer of the uterine cervix among 511 patients. Am J Obstet Gynecol. 2003; 189: 118-120.
17. Hopenhayn C, Christian A, Christian WJ, et al., Prevalence of human papillomavirus types in invasive cervical cancers from 7 US cancer registries before vaccine introduction. J Low Genit Tract Dis. 2014; 18: 182-189.
18. Zhao C, Li Z, Nayar R, et al., Prior high-risk human papillomavirus testing and Papanicolaou test results of 70 invasive cervical carcinomas diagnosed in 2012: results of a retrospective multicenter study. Arch Pathol Lab Med. 2015; 139: 184-188.
19. Zhao FH, Lewkowitz AK, Hu SY, et al., Prevalence of human papillomavirus and cervical intraepithelial neoplasia in China: a pooled analysis of 17 population-based studies. Int J Cancer. 2012; 131: 2929-2938.
20. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM,. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010; 127: 2893-2917.
21. Zheng B, Austin RM, Liang X, et al., Bethesda system reporting rates for conventional Papanicolaou tests and liquid-based cytology in a large Chinese, College of American Pathologists-certified independent medical laboratory: analysis of 1 394 389 Papanicolaou test reports. Arch Pathol Lab Med. 2015; 139: 373-377.
22. Zheng B, Austin RM, Liang X, et al., PPV of an HSIL cervical cytology result in China's largest CAP-certified laboratory. J Am Soc Cytopathol. 2015; 4: 84-89.
23. Zhang Y, Huang H, Duan M, Deng S,. Liquid-chip technique in investigation of HPV infections and genotyping of female patients in Chongqing. Int J Lab Med. 2013; 34: 2703-2704.
24. Pirog EC, Lloveras B, Molijn A, et al., HPV prevalence and genotypes in different histological subtypes of cervical adenocarcinoma, a worldwide analysis of 760 cases. Mod Pathol. 2014; 27: 1559-1567.
25. Austin RM, Zhao C,. Type 1 and type 2 cervical carcinomas: some cervical cancers are more difficult to prevent with screening. Cytopathology. 2012; 23: 6-12.
26. Igidbashian S, Schettino MT, Boveri S, et al., Tissue genotyping of 37 in situ and invasive cervical cancer with a concomitant negative HC2 HPV DNA test. J Low Genit Tract Dis. 2014; 18: 87-91.
27. Boulet GA, Benoy IH, Depuydt CE, et al., Human papillomavirus 16 load and E2/E6 ratio in HPV16-positive women: biomarkers for cervical intraepithelial neoplasia 2 in a liquid-based cytology setting. Cancer Epidemiol Biomarkers Prev. 2009; 18: 2992-2999.
28. Phillips S, Garland SM, Tan JH, Quinn MA, Tabrizi SN,. Comparison of the Roche Cobas(®) 4800 HPV assay to Digene Hybrid Capture 2, Roche Linear Array and Roche Amplicor for detection of high-risk human papillomavirus genotypes in women undergoing treatment for cervical dysplasia. J Clin Virol. 2015; 62: 63-65.